Delivery Order SPE2DR25D7059-SPE2DR26F7NTX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,687.44 to AmerisourceBergen Drug Corp for the supply of Verapamil 5 mg/2 mL vials on January 5, 2026, with completion targeted for January 6, 2026. This firm fixed price delivery order was awarded without a set-aside designation through open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery...
- The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp for Verapamil 80 mg tablets (90-count) with a ceiling value of $7,198.33. This firm fixed-price, competitively awarded order was issued on January 28, 2026, with an ultimate completion date of January 29, 2026. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where Amerisourcebergen Drug Corp maintains its corporate office. No set-aside designation was applied to this contract award....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Verapamil 80 mg tablets (90-count units) with a ceiling value of $2,232.84. This non-competitive, firm fixed-price delivery order is set to be completed by December 5, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal...
- The Defense Logistics Agency awarded a delivery order valued at $9,720.01 to AmerisourceBergen Drug Corp for the supply of Verapamil SR 240 mg capsules (100-count units) on January 29, 2026. This firm fixed-price delivery order, which carries an ultimate completion date of January 30, 2026, was competitively awarded without set-aside designation. The products will be delivered to the Conshohocken, Pennsylvania location, which serves as the awardee's corporate headquarters. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $9,032.46 delivery order to AmerisourceBergen Drug Corp for Verapamil 5 mg/2 mL vials on September 2, 2025, with completion expected by September 3, 2025. This non-set-aside contract utilizes firm fixed pricing and is performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a small-value pharmaceutical procurement supporting federal medical supply requirements, consistent with the agency's routine acquisition of...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide Verapamil 120 mg tablets. The $1,556.08 firm fixed-price contract has a completion date of June 16, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military and...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Verapamil 5 mg/2 ml vials. The potential value of the contract is $1,494.93, with a completion date of February 12, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of up to...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,076.89 for Verapamil SR 120 mg capsules (100-count) on September 9, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Verapamil ER PM 300 mg capsules (100-count units) on January 22, 2026, with a ceiling value of $1,731.61. This firm fixed-price delivery order, which has an ultimate completion date of January 23, 2026, represents a task order under a larger indefinite delivery contract vehicle. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation...
- The Defense Logistics Agency awarded a delivery order valued at $1,379.19 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Verapamil ER PM 300 mg capsules (100-count units). This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a non-set-aside competitive award. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- SPE2DR25D7059Indefinite Delivery Contract
- SPE2DR25D7059-SPE2DR26F7NTXDelivery Order
The Defense Logistics Agency awarded a $7,111.95 delivery order to AmerisourceBergen Drug Corp for 90-count packages of Verapamil 80 mg tablets, with an ultimate completion date of January 22, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is being fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor providing critical medical supplies to federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. The contract demonstrates the contractor's established capability to meet federal procurement requirements across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 1/20/26 |